Αποτελέσματα Αναζήτησης
16 Μαΐ 2023 · However, hormone therapy is not recommended to prevent or treat osteoporosis, because there are bone medicines (called bisphosphonates or denosumab) that are very effective and have fewer serious risks.
22 Αυγ 2023 · This topic will review the efficacy of estrogen therapy on the prevention and treatment of postmenopausal bone loss. The approach to osteoporosis management, the benefits and risks of estrogen therapy, and our current recommendations for estrogen use are discussed separately.
The Clinician’s Guide offers concise recommendations regarding prevention, risk assessment, diagnosis, and treatment of osteoporosis in postmenopausal women and men aged 50 years and older. It includes indications for bone densitometry as well as fracture risk thresholds for pharmacologic intervention.
6 Σεπ 2024 · Calcitonin may be administered as a nasal spray or injection. Most people prefer the nasal spray due to ease of use and because the injections tend to cause more nausea and flushing. (See "Calcitonin in the prevention and treatment of osteoporosis".)
injection of 20 µg, reduces vertebral and non-vertebral fractures in postmenopausal women with osteoporosis. 22 It has been shown to reduce the risk of vertebral and non-vertebral, but not hip, fractures. Because it costs considerably more than other options, it is reserved for patients with severe osteoporosis who are unable to tolerate, or seem
severe osteoporosis (ie, low T-score < −2.5 and fractures) or multiple vertebral fractures, we recommend romosozumab treatment for up to 1 year for the reduction of vertebral, hip, and nonvertebral fractures. Technical remark: The recommended dosage is 210 mg monthly by subcutaneous injection for 12 months.
insertion instructions before attempting insertion of Mirena. • Insertion may be associated with some pain and/or bleeding or vasovagal reactions (for example, syncope, bradycardia), or with...
